Becker's Hospital Review - Cardiology

NOVEMBER 25, 2024

Of those, 97 hospitals were recognized for delivering superior clinical outcomes in cardiac care for heart bypass surgery, coronary interventional procedures, heart attack treatment, heart failure treatment and heart valve surgery. Healthgrades published its 2025 Specialty Excellence Awards recipients Oct.

Hospital 105

Hospital Heart attacks Heart Attack Heart Valves 105

American College of Cardiology

JUNE 13, 2024

What are the rates of a permanent pacemaker (PPM) implantation, the predictors of needing a PPM, and long-term clinical outcomes of the third-generation balloon-expandable SAPIEN 3 (S3) transcatheter heart valve (THV)?

Pacemaker 66

Pacemaker TAVR Outcomes Heart Valves 66

American College of Cardiology

FEBRUARY 20, 2025

A unique international task force, comprised of representatives from cardiology and cardiothoracic societies as well as patient representatives, has developed the first standardized set of measures for heart valve disease (HVD).

Heart Valves 46

Heart Valves Cardiothoracic Outcomes Article 46

Frontiers in Cardiovascular Medicine

FEBRUARY 14, 2024

Objective Randomized controlled trials demonstrate the effectiveness of expectation-focused interventions in improving recovery outcomes following cardiac surgery. For dissemination in routine health care, it is important to capture the perspective of affected individuals. In addition, it explores potential barriers and adverse effects.

Heart Valves 64

Heart Valves Research Outcomes 64

Frontiers in Cardiovascular Medicine

FEBRUARY 17, 2025

IntroductionSince TAVR was approved for lower-risk aortic stenosis (AS) patients, managing post-implantation conduction disturbances has become crucial, especially with self-expanding heart valves (SEV). Forty-seven received SEVs using COL, and 50 with CON techniques.

Pacemaker 52

Pacemaker Aortic Stenosis Aortic valve 52

Frontiers in Cardiovascular Medicine

FEBRUARY 5, 2025

In recent years, transcatheter aortic valve replacement (TAVR) has emerged as a popular alternative to the traditional surgical aortic valve replacement. Despite multiple risk factors for PPM, the patient had a successful outcome without major complications.

Aortic valve 52

Aortic valve Aortic TAVR Myocardial Infarction 52

HCPLive

FEBRUARY 16, 2024

Tom Nguyen, MD, discusses a recent study he led comparing outcomes of TAVR explantation based on transcatheter heart valve type.

TAVR 59

TAVR Heart Valves Outcomes 59

DAIC

JUNE 13, 2024

Xeltis synthetic restorative pulmonary heart valve evolves into a fully functioning, natural heart valve through colonization by the patient’s own tissue. Paulo Neves , Chief Medical Officer, Xeltis said: “Our focus is on improving the outcomes for patients on dialysis.

Heart Valves 111

Heart Valves Technology Pulmonary Outcomes 111

American Heart News - Heart News

FEBRUARY 17, 2025

17, 2025 The International Consortium for Health Outcomes Measurement (ICHOM) has developed a globally inclusive standard dataset of 16 patient-centered outcome measures. Embargoed until 4:00 a.m. CT/5:00 a.m. ET Monday, Feb. 17, 2025 DALLAS, Feb.

Heart Valves 60

Heart Valves Outcomes 60

HeartRhythm

APRIL 30, 2024

It is unclear if TLE impacts outcomes in these patients, as they may still have residual hardware. Given the inherent risks of surgery, PHV and LVAD infections are often treated with antibiotics alone.

Heart Valves 40

Heart Valves Defibrillator Pacemaker Outcomes 40

Circulation: Cardiovascular Interventions

JANUARY 22, 2025

Some patients with aortic stenosis may require multiple valve interventions in their lifetime, and choosing transcatheter aortic valve replacement (TAVR) as the initial intervention may be appealing to many. If their transcatheter heart valve degenerates later in life, most will hope to undergo redo-TAVR.

TAVR 73

TAVR Aortic valve Aortic Stenosis 73

DAIC

JUNE 21, 2024

Blood then flows backwards within the heart and may cause symptoms such as shortness of breath and swelling in the abdomen, legs or veins in the neck.

Tricuspid 105

Tricuspid Quality of Life Open-Heart Surgery Interventional Cardiology 105

American College of Cardiology

MARCH 15, 2024

The fifth-generation SAPIEN 3 Ultra Resilia valve (S3UR) transcatheter heart valve (THV), used in TAVR procedures, is associated with lower mean gradients and lower rates of paravalvular leak (PVL) when compared to outcomes from the SAPIEN 3 (S3) and SAPIEN 3 Ultra (S3U) valves, according to a study presented at CRT 2024 and simultaneously published (..)

Outcomes 48

Outcomes TAVR Heart Valves Cardiovascular Interventions 48

Circulation

NOVEMBER 11, 2024

Background:Mechanical heart valve replacement (MHVR) is an effective method for the treatment of severe heart valve disease. Circulation, Volume 150, Issue Suppl_1 , Page A4141755-A4141755, November 12, 2024.

Heart Valves 40

Heart Valves Embolism Thrombosis Quality of Life 40

DAIC

JUNE 11, 2024

The Center will also focus on clinical trials for transcatheter edge-to-edge repair (TEER) devices for tricuspid regurgitation, new devices for transcatheter mitral valve replacement, and advancing the field of robotic valve surgery. “At

Tricuspid 111

Tricuspid Bicuspid/Mitral Heart Valves Innovation 111

Circulation: Cardiovascular Interventions

JANUARY 24, 2025

BACKGROUND:Transcatheter heart valve (THV) underexpansion after transcatheter aortic valve replacement may be associated with worse outcomes. Circulation: Cardiovascular Interventions, Ahead of Print.

Heart Valves 40

Heart Valves Aortic valve TAVR Aortic 40

Frontiers in Cardiovascular Medicine

FEBRUARY 25, 2024

Aims To evaluate the procedural and clinical outcome of COMBO therapies compared with M-TEER alone. Methods We included consecutive patients undergoing COMBO and M-TEER between March 2015 and April 2018 at our Heart Valve Center, while excluding patients presenting a case of redo or with previous MV surgery.

Bicuspid/Mitral 59

Bicuspid/Mitral Outcomes Anatomy Heart Valves 59

American College of Cardiology

APRIL 4, 2024

What are the outcomes with transfemoral transcatheter aortic valve implantation (TAVI) in patients with pure aortic regurgitation (AR) using the Trilogy transcatheter heart valve?

Aortic valve 53

Aortic valve Heart Valves Aortic Outcomes 53

Open Heart

SEPTEMBER 4, 2023

The existing treatment pathway for transcatheter aortic valve implantation (TAVI) traditionally relies on tertiary Heart Valve Centre workup. A novel pathway with emphasis on comprehensive patient workup at a local centre, alongside close collaboration with a Heart Valve Centre, may help reduce the time to TAVI.

Heart Valves 52

Heart Valves Aortic valve Aortic Outpatient 52

Circulation: Cardiovascular Interventions

NOVEMBER 20, 2023

BACKGROUND:Redo transcatheter aortic valve implantation (TAVI) is increasing as patients outlive their transcatheter heart valves (THVs) and present with bioprosthetic valve failure. Procedural and outcome data were obtained from 10 patients who had undergone Redo TAVI for Lotus bioprosthetic valve failure in 5 centers.

Aortic valve 40

Aortic valve Heart Valves Aortic Cardiovascular Interventions 40

DAIC

JUNE 24, 2024

I’m also excited to work closely with my peers on the JACC editorial team as we help shape contemporary research priorities, and as such, propel improvements in clinical care to ultimately improve patient outcomes.” Levine Early Career Clinical Investigator Award from the American Heart Association.

Heart Failure 100

Heart Failure Transplant Interventional Cardiology Research 100

Circulation: Cardiovascular Interventions

OCTOBER 17, 2023

BACKGROUND:Data concerning the outcomes of transcatheter aortic valve replacement in type 0 bicuspid aortic stenosis (AS) are scarce. Self-expanding transcatheter heart valves were used in the majority of patients (n=1160; 91.4%). Circulation: Cardiovascular Interventions, Ahead of Print. Poverall=0.765; 1 year: 1.4%

Aortic valve 40

Aortic valve Bicuspid/Mitral Aortic Tricuspid 40

DAIC

JANUARY 31, 2024

TEE is also a valuable tool for minimally invasive heart surgeries and procedures, transforming the treatment of damaged heart valves and congenital heart defects [2]. The clarity and perspective that come with 3D images exceed 2D alternatives.

Ultrasound 111

Ultrasound Technology Innovation Heart Valves 111

European Journal of Heart Failure

FEBRUARY 19, 2024

Tricuspid regurgitation (TR): frequency, clinical presentation, management and outcome among patients with severe left-sided valvular heart disease in Europe. ESC-EORP, European Society of Cardiology-EURObservational Research Programme; TV, tricuspid valve.

Tricuspid 40

Tricuspid Heart Disease Bicuspid/Mitral Heart Valves 40

Frontiers in Cardiovascular Medicine

JULY 21, 2024

IntroductionEnhanced Recovery After Surgery (ERAS) protocols represent a paradigm shift in perioperative care, aim to optimize patient outcomes and accelerate recovery. These findings have broad implications for improving patient care outcomes and advancing perioperative practices in cardiac surgery settings.

Heart Valves 59

Heart Valves Academic Nursing Innovation 59

Journal of Cardiothoracic Surgery

AUGUST 29, 2024

The patient underwent a successful TAVI procedure using the XL-Myval 32 mm transcatheter heart valve (THV) via an anterior right mini-thoracotomy with a direct aortic approach. The patient recovered well post-operatively with good hemodynamic resolution.

Aortic 52

Aortic Aortic valve Heart Valves Innovation 52

DAIC

FEBRUARY 21, 2024

Image courtesy of Henry Ford Health milla1cf Wed, 02/21/2024 - 19:07 February 21, 2024 — An 80-year-old woman from Frankenmuth, Michigan is the first Henry Ford Health structural heart disease patient—and the first ever in Michigan—to receive a new transcatheter heart valve device for treating severe tricuspid regurgitation.

Heart Failure 105

Heart Failure Open-Heart Surgery Tricuspid Heart Disease 105

Circulation: Cardiovascular Interventions

NOVEMBER 20, 2023

Transcatheter aortic valve replacement (TAVR) is increasingly being performed in younger and lower surgical risk patients. Reintervention for failed transcatheter heart valves will likely increase in the future as younger patients are expected to outlive the initial bioprosthesis.

Aortic valve 40

Aortic valve Aortic TAVR Heart Valves 40

DAIC

OCTOBER 21, 2024

tim.hodson Mon, 10/21/2024 - 15:52 Earlier this year, Materialise, a global supplier of 3D printing software and services, acquired FEops , a Belgian company that develops AI-driven simulation technology to improve procedure efficiency and clinical outcomes for structural heart interventions.

Anatomy 52

Anatomy Technology Heart Valves Heart Disease 52

ADN Center of Excellence

JANUARY 14, 2024

Last week marked a significant milestone as the center of excellence for Transcatheter Aortic Valve Implantation (TAVI) procedures hosted a highly successful TAVI Masterclass. Dr. Ibrahim Halil Kurt, renowned for his pioneering contributions to heart valve disease, the event featured live demonstrations of five intricate TAVI cases.

Interventional Cardiology 59

Interventional Cardiology Education Heart Valves Aortic valve 59

Journal of the American Heart Association

FEBRUARY 24, 2025

Differenceindifferences analyses were used to compare differences in outcomes before (20142015) and after (20182019; 2year CR period=20162017) the CR period between participants and nonparticipants.ResultsWe identified 57 668 CReligible beneficiaries after matching, with equal numbers of participants and nonparticipants.

Medicare 45

Medicare Coronary Artery Bypass Graft Cardiac Rehabilitation Inpatient 45

ADN Center of Excellence

JANUARY 14, 2024

Last week marked a significant milestone as the center of excellence for Transcatheter Aortic Valve Implantation (TAVI) procedures hosted a highly successful TAVI Masterclass. Dr. Ibrahim Halil Kurt, renowned for his pioneering contributions to heart valve disease, the event featured live demonstrations of five intricate TAVI cases.

Research 52

Research Education Heart Valves Aortic valve 52

DAIC

JUNE 11, 2024

The Center will also focus on clinical trials for transcatheter edge-to-edge repair (TEER) devices for tricuspid regurgitation, new devices for transcatheter mitral valve replacement, and advancing the field of robotic valve surgery. “At

Tricuspid 52

Tricuspid Bicuspid/Mitral Heart Valves Innovation 52

DAIC

MARCH 12, 2024

milla1cf Tue, 03/12/2024 - 16:48 March 12, 2024 — Medtronic plc , a global leader in healthcare technology, today announced two late-breaking data presentations on four-year outcomes from the Evolut Low Risk Trial. mmHg SAVR; p "The Evolut TAVR System continues to demonstrate positive clinical outcomes compared to SAVR.

TAVR 52

TAVR Aortic valve Aortic Stenosis 52

Frontiers in Cardiovascular Medicine

JANUARY 7, 2024

Material and Methods Patient-specific 3D-printed pulmonary artery geometries of five patients who underwent PPVI using Pulsta transcatheter heart valve (THV) ® were tested in a modified ViVitro pulse duplicator system®. Various valve sizes were subjected to 10 cycles of testing at different cardiac output levels.

Pulmonary 49

Pulmonary Heart Valves Innovation Technology 49

Journal of the American Heart Association

NOVEMBER 28, 2023

Journal of the American Heart Association, Volume 12, Issue 23 , December 5, 2023. BackgroundCardiovascular calcification, characterized by deposition of calcium phosphate in the arterial wall and heart valves, is associated with cardiovascular morbidity and mortality and is commonly seen in aging, diabetes, and chronic kidney disease.

Kidney Disease 40

Kidney Disease Heart Valves Diabetes Outcomes 40

Journal of the American Heart Association

JANUARY 16, 2024

The primary outcome is the mean difference between the intervention versus control groups in distance walked on the 6‐minute walk test (ie, functional capacity) at 12 weeks post randomization.

Coronary Artery Bypass Graft 40

Coronary Artery Bypass Graft Technology Cardiac Rehabilitation Quality of Life 40